Race Oncology Limited
ASX:RAC.AX
1.575 (AUD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 4.003 | 3.134 | 0.708 | 0.387 | 0.159 | 0.229 | 0.17 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 2.614 | 0.281 | 0.281 | 0.281 | 0.281 | 0.281 | 0.251 | 0.25 | 0 | 0 | 0 | 0 |
| Gross Profit
| 1.39 | 2.853 | 0.427 | 0.106 | -0.122 | -0.053 | -0.081 | -0.25 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0.347 | 0.91 | 0.603 | 0.274 | -0.764 | -0.231 | -0.473 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 10.977 | 7.596 | 5.832 | 2.2 | 1.277 | 0.956 | 1.746 | 1.211 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0.914 | 1.524 | 0.614 | 0.67 | 0.487 | 1.208 | 2.785 | 1.808 | 0.368 | 0.078 | 0.095 | 0.013 |
| Selling & Marketing Expenses
| 0.431 | 0.323 | 0.177 | 0.174 | 0.104 | 1.094 | 1.081 | 0.551 | 0.054 | 0 | 0 | 0 |
| SG&A
| 3.793 | 5.11 | 5.373 | 3.995 | 2.403 | 2.526 | 4.332 | 2.582 | 0.496 | 0.078 | 0.095 | 0.013 |
| Other Expenses
| 0 | 3.134 | 0.708 | 0.425 | 0.256 | 0.229 | 0.17 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 14.77 | 12.706 | 11.205 | 6.195 | 3.679 | 3.482 | 6.078 | 3.792 | 0.496 | 0.088 | 0.095 | 0.013 |
| Operating Income
| -13.381 | -12.987 | -11.486 | -6.476 | -3.96 | -3.763 | -6.329 | -4.042 | -0.496 | -0.091 | -0.095 | -0.013 |
| Operating Income Ratio
| -3.342 | -4.143 | -16.227 | -16.718 | -24.85 | -16.469 | -37.173 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -0.439 | -0.071 | -0.424 | -0.252 | -0.045 | -0.125 | -0.148 | -0.129 | 0.178 | 0.003 | 0.003 | 0.003 |
| Income Before Tax
| -13.819 | -13.058 | -11.91 | -6.728 | -4.005 | -3.888 | -6.477 | -4.172 | -0.318 | -0.087 | -0.092 | -0.01 |
| Income Before Tax Ratio
| -3.452 | -4.166 | -16.826 | -17.367 | -25.132 | -17.015 | -38.04 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| -4.003 | -3.134 | -0.708 | -0.387 | -0.159 | -0.229 | -0.17 | 0 | 0.113 | 0.003 | 0.003 | 0.003 |
| Net Income
| -13.819 | -9.923 | -11.202 | -6.34 | -3.846 | -3.659 | -6.306 | -4.172 | -0.318 | -0.087 | -0.092 | -0.01 |
| Net Income Ratio
| -3.452 | -3.166 | -15.826 | -16.367 | -24.132 | -16.015 | -37.04 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.084 | -0.062 | -0.073 | -0.048 | -0.036 | -0.046 | -0.094 | -0.079 | -0.006 | -0.08 | -0.008 | -0.001 |
| EPS Diluted
| -0.084 | -0.062 | -0.073 | -0.048 | -0.036 | -0.046 | -0.094 | -0.079 | -0.006 | -0.08 | -0.008 | -0.001 |
| EBITDA
| -14.203 | -12.706 | -11.205 | -6.195 | -3.679 | -3.482 | -6.078 | -3.792 | -0.496 | 0.003 | 0.003 | 0.003 |
| EBITDA Ratio
| -3.548 | -4.054 | -15.83 | -15.992 | -23.086 | -15.238 | -35.699 | 0 | 0 | 0 | 0 | 0 |